venBio has a different profile from a typical venture capital firm: each member of the investment team holds a medical doctorate, a scientific doctorate, or both. Dr. Yamanaka shares how venBio assesses the market potential of therapeutics and technologies that may be years away from reaching patients.
Breakthrough innovation doesn’t just occur on its own. It requires focus, hard work, and being connected to the right people, places, and resources to make it all happen. Our new platform supports all these needs. Bringing health care entrepreneurs, startups, and industry experts together to bring breakthrough innovations to market, all for one shared mission—to benefit patients.